Growth hormone–releasing hormone (GHRH), also known as somatocrinin among other names in its endogenous form and as somatorelin (INN) in its pharmaceutical form, is a releasing …

2005年7月1日 · Three maleimido derivates of human GH-releasing factor (hGRF) 1–29 were synthesized and bioconjugated to human serum albumin ex vivo. All three human serum …

We conclude that the optimal dose required to elicit maximum GH release with minimal unwanted effects is 80 micrograms in adults. These are related to the dose and observed for doses up to …

1986年1月1日 · We conclude that the optimal dose required to elicit maximum GH release with minimal unwanted effects is 80 μg in adults. These are related to the dose and observed for …

1986年1月1日 · 人类生长激素释放因子（hGRF）的最新可用性鼓励了对人类生长激素分泌的全面研究。 而且，现在有可能提出这种激素的治疗 应用。 在本文中，我们报告了在三种方案中， …

Transgenic mice expressing the human growth hormone-releasing factor (hGRF) gene linked to the metallothionein promoter exhibit high circulating levels of hGRF and GH and increased …

2003年9月26日 · Growth hormone-releasing factor (GRF) is a secreted hypothalamic 44 amino acids peptide involved in the regulation of the expression and release of growth hormone (GH) …

Three ranges of doses of growth hormone releasing factor (2.5-80 micrograms, 80-320 micrograms and 75-600 micrograms) were intravenously administered to healthy young …

1985年1月1日 · Solid phase peptide synthesis has been successfully applied to the preparation of GRF found in human hypothalamus (hGRF). A series of peptides structurally unrelated to the …

Three ranges of doses of growth hormone releasing factor (2.5–80 µg, 80–320 µg and 75–600 µg) were intravenously administered to healthy young volunteers in three double blind studies. …